Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study

December 7, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

HAMILTON, N.J., Dec. 7, 2010 /- MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized Ratings in their pivotal Phase 3 dermatology study.   Cipher recently...

New Trial Studies Link Between Stroke and Atrial Fibrillation

December 7, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Dec. 7, 2010 /PRNewswire-USNewswire/ -- One evening last March, Larry Ambrose left his bed in the middle of the night to check the time. Much to the 71-year-old's surprise, he was only able to see three out of the four glowing numbers on the digital clock in his kitchen. Ambrose...

Passages Malibu Drug and Alcohol Treatment Center Announces Launch of Cutting-Edge 'Brain Paint' Neurofeedback Therapy Scientifically Proven to Reduce Addiction Relapse Rate I...

December 7, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

MALIBU, Calif., Dec. 7, 2010 /- The world-renowned Passages Malibu, the state-of-the-art one-on-one holistic drug and alcohol treatment center, today announced the launch of the "Brain Paint" Neurofeedback, scientifically proven to reduce relapse, as the latest cutting-edge therapy...

Advertisement

Michael Jackson's Death Could Have Been Avoided With a Brain Monitor Says Anesthesiologist

December 7, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

NEWPORT BEACH, Calif., Dec. 7, 2010 /- About 80 percent of the surgeries performed in the U.S. put patients at risk of being inflicted with delirium, dementia or death because a brain monitor is not used by the anesthesiologist. That is one of the secrets unveiled in a new book recently...

Boston Scientific Welcomes Publication of Analysis of Patients Monitored by the LATITUDE® Patient Management System

December 7, 2010 4:33 am | by Boston Scientific | News | Comments

Patients experienced a 50 percent relative reduction in risk of death compared to in-clinic follow-up

Boston Scientific Welcomes Publication of Analysis of Patients Monitored by the LATITUDE® Patient Management System

December 7, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Dec. 7, 2010 /- Boston Scientific Corporation (NYSE: BSX ) today welcomed the publication of an analysis from its ALTITUDE® Clinical Science program in the current issue of Circulation that showed patients followed by the LATITUDE® Patient Management system...

InfraReDx Announces Publication of a Case Report in Circulation Highlighting Novel Clinical Finding with LipiScanâ„¢ Coronary Imaging System

December 7, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Dec. 7, 2010 /- InfraReDx, Inc. , a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced the publication of a case report in Circulation describing the association of stent thrombosis with lipid core plaque as...

Advertisement

Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Adverse Event Pilot Program for Medical Pro...

December 7, 2010 4:30 am | by U.S. Food & Drug Administration | News | Comments

The FDA is announcing an opportunity for public comment on the proposed collection of certain information by the Agency.

China-Biotics Attended National Probiotics Seminar

December 7, 2010 2:33 am | by Bio-Medicine.Org | News | Comments

SHANGHAI, Dec. 7, 2010 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics" or "the Company"), (Nasdaq: CHBT ) the leading developer, manufacturer and distributor of probiotics products in China, today announced that a delegation from the Company's research and development...

Apexigen, Inc. Announces Collaboration for Antibody Discovery

December 7, 2010 2:33 am | by Bio-Medicine.Org | News | Comments

BURLINGAME, Calif., Dec. 7, 2010 /- Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and...

New UCLA study raises questions about genetic testing of newborns

December 6, 2010 10:34 pm | by EurekAlert | News | Comments

(American Sociological Association) Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.

Influenza virus strains show increasing drug resistance and ability to spread

December 6, 2010 10:34 pm | by EurekAlert | News | Comments

(Infectious Diseases Society of America) Two new studies raise public health concerns about increasing antiviral resistance among certain influenza viruses, their ability to spread, and a lack of alternative antiviral treatment options. The findings are published in the Jan. 1 issue of...

Advertisement

KLS Martin's SonicWeld Rx Changing the Face of Craniomaxillofacial Plate Fixation

December 6, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

TORONTO, Dec. 6, 2010 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, US craniomaxillofacial plate and screw market growth will be driven by uptake of new resorbable polymers and novel implantation techniques. KLS Martin's...

diaDexus to Present at the Canaccord Genuity Healthcare Conference

December 6, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO, Calif., Dec. 6, 2010 /- diaDexus, Inc. (OTC Bulletin Board: DDXS ), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans to...

CTCs Predict Poor Outcome From Blood Stem Cell Transplantation Therapy for Metastatic Breast Cancer

December 6, 2010 7:34 am | by AACR | News | Comments

• High-dose chemotherapy and autologous stem cell transplantation is effective therapy. • Therapy may release cancer stem-like cells from bone marrow. • Patients who had low circulating tumor cells did well. SAN ANTONIO - Metastatic breast cancer patients who had circulating tumor cells...

In the Treatment of COPD, Greater Use in the Primary Care Setting Will Strengthen Spiriva's Position Among Sales Leaders

December 6, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Dec. 6, 2010 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Boehringer Ingelheim/Pfizer's Spiriva will most likely strengthen its position among the sales leaders for the treatment of...

Compumedics Home Sleep Testing System Selected for Use in US National Institute of Health (NIH)-Sponsored Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study

December 6, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

CHARLOTTE, N.C., Dec. 6, 2010 /- Compumedics USA, Inc. (CMP.ASX) today announced its new Somte® PSG portable sleep-testing systems were chosen as part of a major new study to further investigate the link between sleep disorders and cardio-vascular disease in various ethnic and racial...

Wells Fargo Practice Finance Named Preferred Provider to the American Optometric Association's Member Advantage Program

December 6, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

EMERYVILLE, Calif., Dec. 6, 2010 /- Wells Fargo Practice Finance, formerly known as Matsco, announced today an agreement to become the preferred provider for optometric practice and equipment financing for American Optometric Association (AOA) members. The affinity relationship through...

CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti

December 6, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

SANTA BARBARA, Calif., Dec. 6, 2010 /- Direct Relief International announced today that CSL Behring has donated critically needed medical supplies to assist cholera patients in Haiti. The products will be used at Justinian University Hospital (JUH) in Cap-Haitien. JUH is the main public...

Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm

December 6, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Dec. 6, 2010 /- Following the annual meeting of its stockholders on Friday, December 3, 2010, Vermillion, Inc. (Nasdaq: VRML ) announced that its stockholders approved the reappointment of Gail S. Page, John F. Hamilton and Dr. William C. Wallen as directors of the Company....

Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting

December 6, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 6, 2010 /PRNewswire/ -- Cylene Pharmaceuticals, Inc. has been selected to present data describing the activity of their first-in-class CK2 inhibitor at the 52nd Annual Meeting of the American Society of Hematology (ASH), to be held on December 4-7 in Orlando, FL, the...

CareFusion to Provide Pyxis® Point-of-Care Products to Veterans Affairs Hospitals Nationwide

December 6, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 6, 2010 /- CareFusion (NYSE: CFN ), a leading, global medical device company, today announced the award of the Pyxis® point-of-care verification suite of products across 153 U.S. Department of Veteran Affairs (VA) medical centers and 17 outpatient centers. (Logo:...

Fuisz Pharma Releases Clinical Photos of Its Opioid Abuse Detection System

December 6, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

MIAMI, Dec. 6, 2010 /PRNewswire-USNewswire/ -- Fuisz Pharma today released photos of what the clinician will see in a standard nasal otoscopic exam in the case of a patient abusing an opioid, like Oxycontin® and others, through snorting. A food safe dye included in the tablet creates...

NIH-sponsored panel issues comprehensive US food allergy guidelines

December 6, 2010 4:32 am | by EurekAlert | News | Comments

(NIH/National Institute of Allergy and Infectious Diseases) An expert panel sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has issued comprehensive US guidelines to assist health care professionals in diagnosing food...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading